Teleflex showcased its complex percutaneous coronary intervention (PCI) product portfolio, recently acquired from the purchase of Vascular Solutions, and the new Arrow AC3 Optimus intra-aortic balloon (IABP) at EuroPCR (16–19 May, Paris, France).
The new Arrow AC3 Optimus IABP is designed to help a weakened heart pump blood and can deliver IABP therapy to a broad range of patients, even those not previously considered candidates for IABP therapy. Clinicians may use the pump on patients with the most severe arrhythmias or with heart rates as high as 200 beats per minute.
It has a third-generation AutoPilot Mode, which uses proprietary algorithms to address key clinical challenges and to simplify the delivery of IABP therapy. In AutoPilot Mode, the Arrow AC3 Optimus IABP automatically adjusts timing and triggering parameters, freeing clinicians to focus on the patient rather than the pump. Additionally, the Arrow AC3 Optimus IABP includes several exclusive algorithms, such as WAVE inflation timing, deflation timing management, and best signal analysis, which optimise key functions of the IABP to deliver therapy to the most challenging patients.